EHR

Behavioral/Mental Health Software Market worth $8.43 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 20, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Behavioral/Mental Health Software Market is projected to reach...

Burntide Gummies Launch 2026 | Advanced Weight Loss Formula Highlights Ingredients, Supplement Facts Available in USA, UK, CA, By BurnTide.

BurnTide Announcing updated ingredient information, supplement facts, usage guidance, and customer support details, giving consumers a complete overview before choosing...

Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN

Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in...

error: Content is protected !!